Risk of cancer in patients with myasthenia gravis.
Evoli
A
A
Institute of Neurology, Catholic University, Rome, Italy.
Batocchi
A P
AP
Tonali
P
P
Marciano
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000150:complications* / Q000628:therapy; D009369:Neoplasms / Q000453:epidemiology*; D012189:Retrospective Studies; D012307:Risk Factors; D013945:Thymoma / Q000453:epidemiology* / Q000601:surgery; D013953:Thymus Neoplasms / Q000453:epidemiology* / Q000601:surgery; D013997:Time Factors
D007166:Immunosuppressive Agents